Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Veilleux

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Diabetes Reports|November 6, 2019
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes MellitusAlain Veilleux, Vincenzo Di Marzo, Cristoforo Silvestri
Endocrinology|December 18, 2004
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistanceLeila Khamzina, Alain Veilleux, Sébastien Bergeron, et al.
International Journal of Molecular Sciences|September 9, 2020
Gut Microbiota and Intestinal Trans-Epithelial PermeabilityBénédicte Allam-Ndoul, Sophie Castonguay-Paradis, Alain Veilleux
Molecular and Cellular Endocrinology|November 22, 2008
Androgen metabolism in adipose tissue: recent advancesKarine Blouin, Alain Veilleux, Van Luu-The, et al.
Molecular Endocrinology (Baltimore, Md.)|March 6, 2010
Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytesAlain Veilleux, Vanessa P Houde, Kerstin Bellmann, et al.
Endocrinology|December 4, 2004
Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytesFrédéric Tremblay, AnneMarie Gagnon, Alain Veilleux, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in womenAlain Veilleux, Caroline Rhéaume, Marleen Daris, et al.
Metabolism: Clinical and Experimental|April 21, 2009
Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in womenAlain Veilleux, Karine Blouin, Caroline Rhéaume, et al.
Diabetes|March 23, 2011
Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in womenAlain Veilleux, Maude Caron-Jobin, Suzanne Noël, et al.
Diabetology & Metabolic Syndrome|April 16, 2020
Plasma biomarkers of small intestine adaptations in obesity-related metabolic alterationsCatherine Lalande, Jean-Philippe Drouin-Chartier, André J Tremblay, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Diabetes Reports|November 6, 2019
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes MellitusAlain Veilleux, Vincenzo Di Marzo, Cristoforo Silvestri
Endocrinology|December 18, 2004
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistanceLeila Khamzina, Alain Veilleux, Sébastien Bergeron, et al.
International Journal of Molecular Sciences|September 9, 2020
Gut Microbiota and Intestinal Trans-Epithelial PermeabilityBénédicte Allam-Ndoul, Sophie Castonguay-Paradis, Alain Veilleux
Molecular and Cellular Endocrinology|November 22, 2008
Androgen metabolism in adipose tissue: recent advancesKarine Blouin, Alain Veilleux, Van Luu-The, et al.
Molecular Endocrinology (Baltimore, Md.)|March 6, 2010
Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytesAlain Veilleux, Vanessa P Houde, Kerstin Bellmann, et al.
Endocrinology|December 4, 2004
Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytesFrédéric Tremblay, AnneMarie Gagnon, Alain Veilleux, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in womenAlain Veilleux, Caroline Rhéaume, Marleen Daris, et al.
Metabolism: Clinical and Experimental|April 21, 2009
Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in womenAlain Veilleux, Karine Blouin, Caroline Rhéaume, et al.
Diabetes|March 23, 2011
Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in womenAlain Veilleux, Maude Caron-Jobin, Suzanne Noël, et al.
Diabetology & Metabolic Syndrome|April 16, 2020
Plasma biomarkers of small intestine adaptations in obesity-related metabolic alterationsCatherine Lalande, Jean-Philippe Drouin-Chartier, André J Tremblay, et al.
Pageof 5